KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) EPS (Basic): 2009-2024

Historic EPS (Basic) for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to -$0.38.

  • Arbutus Biopharma's EPS (Basic) rose 60.00% to -$0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.23, marking a year-over-year increase of 46.51%. This contributed to the annual value of -$0.38 for FY2024, which is 13.64% up from last year.
  • Latest data reveals that Arbutus Biopharma reported EPS (Basic) of -$0.38 as of FY2024, which was up 13.64% from -$0.44 recorded in FY2023.
  • Arbutus Biopharma's 5-year EPS (Basic) high stood at -$0.38 for FY2024, and its period low was -$1 during FY2020.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.44 (2023), whereas its average is -$0.43.
  • Data for Arbutus Biopharma's EPS (Basic) shows a peak YoY spiked of 65.40% (in 2020) over the last 5 years.
  • Arbutus Biopharma's EPS (Basic) (Yearly) stood at -$1 in 2020, then climbed by 17.00% to -$0.83 in 2021, then soared by 44.58% to -$0.46 in 2022, then increased by 4.35% to -$0.44 in 2023, then climbed by 13.64% to -$0.38 in 2024.